Top match · Trial
The IMAGINE study: A phase 3b open label, single arm study to assess the effect of depemokimab on airway structure and function in asthma with Type 2 inflammation characterized by an eosinophilic phenotype utilizing quantitative high-resolution CT and bronchoscopic airway sampling in a sub study View profile → 🇺🇸 Search Americas
Global entity results · articles filtered to FDA
2 intelligence results for “type 2 inflammation”
1 trials · 1 pipelines
🇺🇸 Americas articles · global entities